Caladrius Biosciences CEO David Mazzo's 2019 pay slips 19% to $1.5M
Caladrius Biosciences reports 2019 executive compensation
By ExecPay News
Published: April 28, 2021
Caladrius Biosciences reported fiscal year 2019 executive compensation information on April 28, 2021.
In 2019, five executives at Caladrius Biosciences received on average a compensation package of $831K, a 33% decrease compared to previous year.
Average pay of disclosed executives at Caladrius Biosciences
David J. Mazzo, Chief Executive Officer, received $1.5M in total, which decreased by 19% compared to 2018. 39% of Mazzo's compensation, or $597K, was in salary. Mazzo also received $279K in bonus, $230K in option awards, $401K in stock awards, as well as $33K in other compensation.
Douglas Losordo, Chief Medical Officer, received a compensation package of $890K, which decreased by 12% compared to previous year. 50% of the compensation package, or $443K, was in salary.
Joseph Talamo, Chief Financial Officer, earned $677K in 2019, a 19% decrease compared to previous year.
Todd Girolamo, General Counsel, received $658K in 2019.
William K. Sietsema, Vice President, Global Regulatory Affairs, earned $390K in 2019.
Related executives
Todd Girolamo
Caladrius Biosciences
General Counsel
William Sietsema
Caladrius Biosciences
Vice President, Global Regulatory Affairs
David Mazzo
Caladrius Biosciences
Chief Executive Officer
Douglas Losordo
Caladrius Biosciences
Chief Medical Officer
Joseph Talamo
Caladrius Biosciences
Chief Financial Officer
You may also like
Source: SEC filing on April 28, 2021.